Latest filing: trade of 17 Apr 2026 for Vivoryon Therapeutics N.V.. The register gives no publication date. Read the official filing
No signal scores available.
Irsfeld M. discloses dealings in Vivoryon Therapeutics N.V. to AFM. The record holds 2 filings, for trades running from 16 October 2025 to 17 April 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 22 April 2026: a share grant, in Vivoryon Therapeutics N.V. These figures are compiled from regulatory filings published by AFM. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations